MedPath

Evaluation of the efficacy of the injection of botulinum toxin A vs scopolamine patches in the treatment of drooling in children with cerebral palsy

Phase 1
Conditions
Children with cerebral palsy aged 4 years old and over, presenting a pathological drooling
MedDRA version: 20.1Level: PTClassification code 10008129Term: Cerebral palsySystem Organ Class: 10010331 - Congenital, familial and genetic disorders
Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
Registration Number
EUCTR2021-000095-10-FR
Lead Sponsor
Hospices Civils de Lyon
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
130
Inclusion Criteria

•Aged 4 to 17 years old,
•Cerebral palsy (stable brain injury acquired before the age of 2 years), with disabling drooling,
•Significant impact of drooling on the children (DIS score =40),
•Affiliated or beneficiary of a social security scheme,
•At least one of the parents understanding and speaking French,
•Written consent form signed by both parents
•Absence of known current pregnancy and breastfeeding
Are the trial subjects under 18? yes
Number of subjects for this age range: 130
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

•Previous history of surgery for drooling,
•Injection of botulinum toxin (all locations) in the 3 months prior to the inclusion,
•Treatment by scopolamine patch (Scopoderm®) or other anticholinergic (Artane®, etc.) in the month prior to inclusion,
•Contraindication to the anesthetic or sedation,
•Contraindication to one of the treatments studied (glaucoma, myasthenia, uretroprostatic disorders),
•Injection site infection,
•Swallowing disorder (to saliva) or absence of spontaneous swallowing reflex not investigated by nasoscopy
•On-going or programmed orthodontic treatment over the study period.
•Untreated dental inflammatory condition (dental caries, gingivitis…)

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath